Filing Details

Accession Number:
0000950170-24-007123
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-24 18:44:41
Reporting Period:
2024-01-22
Accepted Time:
2024-01-24 18:44:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1590750 Viridian Therapeutics Inc. VRDN Services-Medical Laboratories (8071) 471187261
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1686157 L.p. Fund Healthcare Fairmount 2001 Market Street
Suite 2500
Philadelphia PA 19103
No No No No
1769651 L.p. Ii Fund Healthcare Fairmount 2001 Market Street
Suite 2500
Philadelphia PA 19103
No No No No
1802528 Fairmount Funds Management Llc 200 Barr Harbor Drive
Suite 400
West Conshohocken PA 19428
No No No No
1830382 Fairmount Healthcare Fund Ii Gp Llc 2001 Market Street, Suite 2500
Philadelphia PA 19103
No No No No
1830383 Fairmount Healthcare Fund Gp Llc 2001 Market Street, Suite 2500
Philadelphia PA 19103
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-01-22 476,190 $21.00 1,839,954 No 4 P Indirect Fairmount Healthcare Fund II LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Fairmount Healthcare Fund II LP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,859 Indirect Fairmount Healthcare Fund LP
Footnotes
  1. Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the securities held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.
  2. Fairmount Funds Management LLC and Fairmount Healthcare Fund GP LLC have voting power and investment power over the securities held by Fairmount Healthcare Fund LP ("Fund I"). They disclaim beneficial ownership of securities held by Fund I for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.